Transgene reports business update and end Q3 2020 financial position
By nh|2020-11-05T16:56:31+01:00November 5th, 2020|Press release|Comments Off on Transgene reports business update and end Q3 2020 financial position
About the Author: nh
Related Posts
- First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy
First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy